CD34 As a Potential Prognostic Indicator for Camrelizumab Response in Advanced Non-Small-cell Lung Cancer: Insights from Digital Spatial Profiling
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY(2024)
Key words
advanced non-small-cell lung cancer,CD34,camrelizumab,digital spatial profiling,immune checkpoint inhibitor resistance
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined